PerkinElmer, Inc. Gains China OK For Neonatal Test Analyzer
PerkinElmer, which offers products for human and environmental health, was granted CFDA approval to market a new fully automated analyzing device, the Genetic Screening Processor®, along with a test that screens for congenital hypothyroidism in newborns. PerkinElmer said the GSP instrument is capable of testing for a wide range of prenatal and neonatal disorders using a spot of dried blood from the infant.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.